As filed with the Securities and Exchange Commission on February 17, 2026
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMDOCS LIMITED
(Exact Name of Registrant as Specified in Its Charter)
| Guernsey | Not Applicable | |
|
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
Hirzel House, Smith Street,
St. Peter Port, Guernsey,
GY1 2NG
(Address including zip code of Principal Executive Offices)
2023 Employee Share Purchase Plan
(Full Title of the Plan)
c/o Matthew E. Smith, Amdocs Inc.
625 Maryville Centre Drive, Suite 200
Saint Louis, Missouri 63141
Telephone:
(314) 212-7000
(Telephone Number, Including Area Code, of Agent For Service)
Copy to:
Michael Kaplan
Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, New York 10017
(212) 450-4000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
| Non-accelerated filer | ☐ (Do not check if a smaller reporting company) | Smaller reporting company | ☐ | |||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 (the “Registration Statement”) is being filed for the purpose of registering 2,200,000 ordinary shares, par value £0.01 per share (“Ordinary Shares”), of Amdocs Limited (the “Registrant”) authorized for issuance pursuant to the Registrant’s 2023 Employee Share Purchase Plan, as amended (the “Plan”). These additional shares were authorized for issuance as a result of the adoption of amendments to the Plan approved by the Registrant’s Board of Directors in November 2025 and shareholders in January 2026.
PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
The information specified in Item 1 and Item 2 of Part I is omitted from this filing and is included in documents sent or provided to participants in the Plan covered by this Registration Statement pursuant to Rule 428(b)(1) of the Securities Act of 1933, as amended (the “Securities Act”).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. INCORPORATION BY REFERENCE.
The Registrant is subject to the informational and reporting requirements of Sections 13(a), 14, and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and in accordance therewith files reports and other information with the Securities and Exchange Commission (the “Commission”). The following documents, which are on file with the Commission, are incorporated in this Registration Statement by reference:
(a) Pursuant to General Instruction E to Form S-8, the contents of the registration statement on Form S-8 (File No. 333-269728) previously filed by the Registrant with respect to Ordinary Shares offered pursuant to the Plan are hereby incorporated by reference herein, and the opinions and consents listed below are filed herewith;
(b) The Registrant’s Annual Report on Form 20-F for the fiscal year ended September 30, 2025 (Registration No. 251571611), as filed by the Registrant on December 15, 2025.
(c) All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the document referred to in (a) above, including the Registrant’s Report on Form 6-K filed on December 16, 2025, January 30, 2026 and February 17, 2026.
(d) The description of the Registrant’s Ordinary Shares contained in the Registrant’s Registration Statement on Form 8-A as filed with the Commission on December 19, 2013 (Registration No. 131288798), including any amendment or report filed for updating such description.
In addition, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of the post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, including any Reports of Foreign Private Issuers on Form 6-K submitted during such period (or portion thereof) that is identified in such form as being incorporated by reference into this Registration Statement, shall be deemed to be incorporated by reference in the Registration Statement and to be part thereof from the date of filing of such documents. The Registrant is not incorporating by reference any documents or portions thereof, whether specifically listed above or filed in the future, that are not deemed “filed” with the Commission.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. EXHIBITS.
| Exhibit Number |
Description | |
| 5.1* | Opinion of Carey Olsen. | |
| 23.1* | Consent of Carey Olsen (included in Exhibit 5.1). | |
| 23.2* | Consent of Ernst & Young LLP. | |
| 24.1* | Power of Attorney (included on the signature page of this Registration Statement). | |
| 99.1* | Amdocs Limited 2023 Employee Share Purchase Plan, as amended. | |
| 107* | Filing Fee Table. | |
* Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, on this 17th day of February, 2026.
| AMDOCS LIMITED | ||
| By: | /s/ Matthew E. Smith | |
| Name: Matthew E. Smith | ||
| Title: Secretary and Authorized Signatory | ||
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of Amdocs Limited, hereby severally constitute Matthew E. Smith and Tamar Rapaport-Dagim (with full power to each of them to act alone), and each of them singly, our true and lawful attorneys-in-fact and agents with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, the Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said Registration Statement, and generally to do all such things in our names and behalf in our capacities as officers and directors to enable Amdocs Limited to comply with all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by said attorneys-in-fact, or any of them, to said Registration Statement and any and all amendments thereto.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date | ||
| /s/ Shuky Sheffer | Director and President & Chief Executive Officer (Principal Executive Officer) |
February 17, 2026 | ||
| Shuky Sheffer | ||||
| /s/ Tamar Rapaport-Dagim | Chief Financial and Chief Operating Officer (Principal Financial Officer and Principal Accounting Officer) |
February 17, 2026 | ||
| Tamar Rapaport-Dagim | ||||
| /s/ Eli Gelman | Chairman of the Board | February 17, 2026 | ||
| Eli Gelman | ||||
| /s/ Robert A. Minicucci | Director | February 17, 2026 | ||
| Robert A. Minicucci | ||||
| /s/ Adrian Gardner | Director | February 17, 2026 | ||
| Adrian Gardner | ||||
| /s/ Rafael de la Vega | Director | February 17, 2026 | ||
| Rafael de la Vega | ||||
| /s/ John A. MacDonald | Director | February 17, 2026 | ||
| John A. MacDonald | ||||
| /s/ Yvette Kanouff | Director | February 17, 2026 | ||
| Yvette Kanouff | ||||
| /s/ Sarah Ruth Davis | Director | February 17, 2026 | ||
| Sarah Ruth Davis | ||||
| /s/ Amos Genish | Director | February 17, 2026 | ||
| Amos Genish | ||||
| /s/ Véronique Morali | Director | February 17, 2026 | ||
| Véronique Morali |
AUTHORIZED REPRESENTATIVE
Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Amdocs Limited, has signed this Registration Statement on February 17, 2026.
| By: | /s/ Matthew E. Smith | |
| Name: Matthew E. Smith | ||
| Title: Secretary and Authorized Signatory |